Ledger.Open graph →
SEC Form D · filed November 17, 2020

GENEOS Therapeutics, Inc

Offering
$12.0M
Sold
$10.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLYMOUTH MEETING, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

James Y. Eadie · Plymouth Meeting, PADirectorJ. J. Kim · Plymouth Meeting, PADirectorNiranjan Y. Sardesai · Plymouth Meeting, PAExec · DirectorCasey J. Cunningham · Plymouth Meeting, PADirectorSamuel J. Broder · Plymouth Meeting, PADirectorSangwoo J. Lee · Plymouth Meeting, PADirectorJan Hammer · MENLO PARK, CADirectorDaniel Gallagher · MENLO PARK, CAExec · DirectorGretchen Howard · MENLO PARK, CADirectorBaiju Bhatt · MENLO PARK, CADirectorAshish Dodia · Wilmington, DEDirectorn.a. NexPoint Real Estate Advisors IX GP, LLC · Dallas, TXDirectorBrian Mitts · Dallas, TXDirectorFrancisco J. Rivera · Austin, TXExec · DirectorSamuel J. Broder · Plymouth Meeting, PADirectorSangwoo J. Lee · Plymouth Meeting, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗